Healthcare Realty Trust (HR) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
30 Apr, 2026Portfolio overview and financial performance
Owns 563 outpatient medical properties totaling 33 million sq. ft. with a $10.6B enterprise value and $6.4B market cap.
Achieved 1Q 2026 normalized FFO per share of $0.41, up 5% YoY, and same store cash NOI growth of 6.9%.
Maintains 92.3% same store occupancy and 93.5% tenant retention, with 2.0M sq. ft. of lease executions and average lease term of 7.7 years.
Increased 2026 normalized FFO per share guidance to $1.59–$1.65 and raised same store cash NOI growth guidance to 3.75%–4.75%.
Net debt to adjusted EBITDA stands at 5.5x, with $1.2B in liquidity and a BBB/Baa2 credit rating.
Strategic initiatives and capital allocation
Completed $1.2B of planned 2025 dispositions at a blended 6.7% cap rate, exiting 14 non-core markets.
Repurchased $100M of common stock in 1Q 2026 and completed new JV acquisition for $89M.
Added two new redevelopment projects with an expected cost of $31M and received $400M in commitments for a new unsecured term loan.
Right-sized quarterly dividend to $0.24/share, saving ~$100M annually, and returned $385M to shareholders in 2025 via dividends.
Redevelopment portfolio is 60% leased, with ~1,000bps improvement since 3Q 2025 and targeted incremental yields of 9–12%.
Market positioning and sector trends
Only REIT focused exclusively on the outpatient medical sector, benefiting from aging demographics and limited new supply.
Sector occupancy at 93%, highest in over 7 years, with market rent growth above 3% and record rent escalators.
Private markets recognize value, with ~$10B average annual investment volume and attractive risk-adjusted returns.
Portfolio concentrated in top 50 MSAs, with deep relationships with leading national and regional health systems.
Improved portfolio quality post-dispositions, with current portfolio occupancy at 92% and better market demographics.
Latest events from Healthcare Realty Trust
- Registering 36M shares for resale by noteholders; no proceeds to company; NYSE-listed at $21.53.HR
Registration filing - High-performing outpatient medical REIT with strong growth, liquidity, and sector leadership.HR
Investor presentation - Q2 2026 net loss, strong NOI growth, raised guidance, and major capital market actions.HR
Q2 2026 - Record leasing and 6.9% NOI growth drove raised guidance and $100M in share repurchases.HR
Q1 2026 - Exceeded 2025 FFO guidance, reduced leverage, and set disciplined 2026 growth targets.HR
Q4 2025 - Leasing strength, asset sales, and raised guidance offset a Q3 net loss and lower rental income.HR
Q3 2025 - Q2 net loss on impairments, but strong leasing and asset sales support 2024 FFO outlook.HR
Q2 2024 - Q1 2025 delivered stable FFO, improved net loss, and strong leasing amid ongoing risks.HR
Q1 2025 - Record leasing, robust FFO growth, and focus on deleveraging set the stage for 2025.HR
Q4 2024